BINP — Bionoid Pharma Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $5.94m
- $6.05m
Annual cashflow statement for Bionoid Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | 2011 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | ARS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.26 | -1.59 | -3.41 | -3.91 | -5.14 |
| Depreciation | |||||
| Non-Cash Items | 0.436 | 0.787 | 2.32 | 1.87 | 3.43 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.253 | 0.39 | 0.566 | 0.267 | 0.897 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.531 | -0.369 | -0.484 | -1.73 | -0.809 |
| Capital Expenditures | -0.001 | -0.005 | -0.002 | -0.011 | -0.01 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.001 | -0.005 | -0.002 | -0.011 | -0.01 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.508 | 0.421 | 0.579 | 2.57 | -0.158 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.004 | 0.019 | 0.112 | 0.837 | -0.983 |